海正藥業(600267.SH):椒江君悦大廈27套公寓已全部出售完畢
格隆匯1月6日丨海正藥業(600267.SH)公佈,公司於2019年12月10日召開的第八屆董事會第六次會議審議,同意公司調整椒江區君悦大廈A座5套公寓的掛牌底價,以不低於評估值201.87萬元的90%(即不低於人民幣182萬元)擇機再次公開掛牌出售,處置價格以實際成交價為準。
公司委託台交所和浙江城鄉拍賣有限公司共同組織椒江區君悦大廈A座5套公寓拍賣事宜。2019年12月18日,台交所在其網站及《台州日報》上發佈了相關拍賣文件,並與浙江城鄉拍賣有限公司共同組織實施交易。
2020年1月6日上午9:30,在台州市府大道777號台州市公共資源交易中心三樓一號開標室,公司委託台交所和浙江城鄉拍賣有限公司共同組織實施公開拍賣椒江區君悦大廈A座5套公寓,最終拍賣成交5套公寓。截至目前,公司位於台州市椒江區君悦大廈A座的27套公寓已全部出售完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.